Brief: Proqr Announces First Quarter 2022 Operating And Financial Results

ProQR Therapeutics NV

05/05/2022 21:33

May 5 (Reuters) - ProQR Therapeutics NV  PRQR.O :
    * PROQR ANNOUNCES FIRST QUARTER 2022 OPERATING AND FINANCIAL
RESULTS
    * Q1 LOSS PER SHARE EUR 0.20
    * CASH RUNWAY INTO 2025
    * PROQR THERAPEUTICS - ENROLLMENT ONGOING IN SIRIUS, A PHASE
2/3
TRIAL OF ULTEVURSEN , FOR USH2A-MEDIATED USHER SYNDROME AND
RETINITIS PIGMENTOSA
    * Q1 EARNINGS PER SHARE VIEW EUR -0.24 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX2JnSbl 
Further company coverage:  PRQR.O 

 ((Reuters.Briefs@thomsonreuters.com;))